NO901083D0 - Fremgangsmaate for fremstilling av nye 1,7-kondenserte 1h-indol-2-carboxylsyre-n-(1,4-benzodiazepin)-3-yl)amider. - Google Patents

Fremgangsmaate for fremstilling av nye 1,7-kondenserte 1h-indol-2-carboxylsyre-n-(1,4-benzodiazepin)-3-yl)amider.

Info

Publication number
NO901083D0
NO901083D0 NO901083A NO901083A NO901083D0 NO 901083 D0 NO901083 D0 NO 901083D0 NO 901083 A NO901083 A NO 901083A NO 901083 A NO901083 A NO 901083A NO 901083 D0 NO901083 D0 NO 901083D0
Authority
NO
Norway
Prior art keywords
lower alkyl
represents hydrogen
halogen
preparation
benzodiazepin
Prior art date
Application number
NO901083A
Other languages
English (en)
Other versions
NO173869B (no
NO901083L (no
NO173869C (no
Inventor
Harald Waldeck
Werner Benson
Horst Zeugner
Klaus-Ullrich Wolf
Peter-Colin Gregory
Derk Hamminga
Ineke Van Wijngaarden
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3907390A external-priority patent/DE3907390A1/de
Priority claimed from DE3907389A external-priority patent/DE3907389A1/de
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of NO901083D0 publication Critical patent/NO901083D0/no
Publication of NO901083L publication Critical patent/NO901083L/no
Publication of NO173869B publication Critical patent/NO173869B/no
Publication of NO173869C publication Critical patent/NO173869C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
NO901083A 1989-03-08 1990-03-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,7-kondenserte 1h-indol-2-carboxylsre-n-(1,4-benzodiazepin-3-yl)-amider NO173869C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3907390A DE3907390A1 (de) 1989-03-08 1989-03-08 Neue 1,7-anellierte 1h-indol-2-carbonsaeure-n-(5-phenyl-1,4-benzodiazepin-3-yl)amide
DE3907389A DE3907389A1 (de) 1989-03-08 1989-03-08 Neue 1,7-anellierte 1h-indol-carbonsaeure-n-(5-alkyl-1,4-benzodiazepin-3-yl)amide

Publications (4)

Publication Number Publication Date
NO901083D0 true NO901083D0 (no) 1990-03-07
NO901083L NO901083L (no) 1990-09-10
NO173869B NO173869B (no) 1993-11-08
NO173869C NO173869C (no) 1994-02-16

Family

ID=25878542

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901083A NO173869C (no) 1989-03-08 1990-03-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,7-kondenserte 1h-indol-2-carboxylsre-n-(1,4-benzodiazepin-3-yl)-amider

Country Status (20)

Country Link
US (1) US5010076A (no)
EP (1) EP0387618B1 (no)
JP (1) JP3010558B2 (no)
KR (1) KR920003627B1 (no)
CN (1) CN1032208C (no)
AT (1) ATE109146T1 (no)
AU (1) AU616835B2 (no)
CS (1) CS390091A3 (no)
DE (1) DE59006544D1 (no)
DK (1) DK0387618T3 (no)
ES (1) ES2057216T3 (no)
FI (1) FI92486C (no)
HK (1) HK1006570A1 (no)
HU (2) HU207317B (no)
IE (1) IE65030B1 (no)
IL (1) IL93401A (no)
NO (1) NO173869C (no)
NZ (1) NZ232774A (no)
PH (1) PH26955A (no)
PT (1) PT93360B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07103105B2 (ja) * 1989-05-12 1995-11-08 杏林製薬株式会社 インドール誘導体及びその製造方法
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
DE4128015A1 (de) * 1991-08-23 1993-02-25 Kali Chemie Pharma Gmbh 1,7-anellierte 2-(piperazinoalkyl)indol-derivate sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindugnen enthaltende arzneimittel
GB9203790D0 (en) * 1992-02-21 1992-04-08 Merck Sharp & Dohme Therapeutic agents
US5360802A (en) * 1992-05-11 1994-11-01 Merck Sharpe & Dohme Ltd. Benzodiazepine derivatives, compositions containing them and their use in therapy
DE4304806A1 (de) * 1993-02-17 1994-08-18 Kali Chemie Pharma Gmbh 5-Phenyl-pyrrolo-1,4-benzoxazin- und -thiazin-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5556969A (en) * 1994-12-07 1996-09-17 Merck Sharp & Dohme Ltd. Benzodiazepine derivatives
NZ314105A (en) 1996-02-02 1997-12-19 Sumitomo Pharma Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring
CN1535682A (zh) * 1998-09-30 2004-10-13 ����ҩƷ��ҵ��ʽ���� 改善膀胱排泄能力的药物
WO2002098865A2 (fr) * 2001-06-07 2002-12-12 Neuro3D Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs
JP2006509832A (ja) * 2002-10-30 2006-03-23 ニューロ３デー サイクリックヌクレオチドホスホジエステラーゼ阻害剤、その調製及び使用
FR2846653B1 (fr) * 2002-10-30 2007-04-20 Neuro3D Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
WO2014098000A1 (en) * 2012-12-17 2014-06-26 Daiichi Sankyo Company, Limited Process for preparation of a tricyclic heterocycle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139584B1 (fr) * 1983-10-17 1988-05-18 Synthelabo Dérivés d'imidazoline, leur préparation et leur application en thérapeutique
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
FR2567126B1 (fr) * 1984-07-06 1986-12-12 Synthelabo Derives de pyrrolo(1,2,3-de) benzoxazine et benzothiazine, leur preparation et leur application en therapeutique
US4628084A (en) * 1986-01-02 1986-12-09 Merck & Co., Inc. Process for 3-acylamino benzodiazepines
IL88615A (en) * 1987-12-10 1992-11-15 Duphar Int Res 1,7-annelated indolecarboxylic acid esters and carboxamides,their preparation and pharmaceutical compositions containing them
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them
FR2652352A1 (fr) * 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.

Also Published As

Publication number Publication date
NO173869B (no) 1993-11-08
KR900014391A (ko) 1990-10-23
CN1045392A (zh) 1990-09-19
PT93360B (pt) 1996-02-29
ES2057216T3 (es) 1994-10-16
FI901154A0 (fi) 1990-03-07
IE65030B1 (en) 1995-10-04
HU901333D0 (en) 1990-05-28
KR920003627B1 (ko) 1992-05-04
AU616835B2 (en) 1991-11-07
HUT53641A (en) 1990-11-28
CS390091A3 (en) 1992-06-17
HU207317B (en) 1993-03-29
IL93401A (en) 1994-08-26
FI92486C (fi) 1994-11-25
HK1006570A1 (en) 1999-03-05
AU5075390A (en) 1990-09-13
FI92486B (fi) 1994-08-15
NO901083L (no) 1990-09-10
DK0387618T3 (da) 1994-08-22
ATE109146T1 (de) 1994-08-15
IL93401A0 (en) 1990-11-29
JPH02273678A (ja) 1990-11-08
NO173869C (no) 1994-02-16
US5010076A (en) 1991-04-23
HU210354A9 (en) 1995-03-28
JP3010558B2 (ja) 2000-02-21
EP0387618A1 (de) 1990-09-19
PH26955A (en) 1992-12-03
NZ232774A (en) 1991-04-26
DE59006544D1 (de) 1994-09-01
PT93360A (pt) 1990-11-07
IE900813L (en) 1990-09-08
CN1032208C (zh) 1996-07-03
EP0387618B1 (de) 1994-07-27

Similar Documents

Publication Publication Date Title
NO901083L (no) Fremgangsmaate for fremstilling av nye 1,7-kondenserte 1h-indol-2-carboxylsyre-n-(1,4-benzodiazepin)-3-yl)amider.
ATE208779T1 (de) Substituierte spiroheterocyclische 1h-3-aryl- pyrrolidin-2,4-dion-derivate, verfahren zu deren herstellung und deren verwendung als schädlingsbekämpfungsmittel
ATE36152T1 (de) Azaprostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
DE69111815D1 (de) Piperazinylderivate mit Affinität zu 5-HT Rezeptoren.
PT83725B (pt) Processo para preparacao de novos derivados da 3-oxadiol-beta-carbolina e 3-carboxilato-beta-carbolina e de composicoes farmaceuticas que os contem
ZA867616B (en) Tetrahydro-beta-carbolines,process for their production and their use as drugs
CA2011658A1 (en) New 1,7-annelated 1h-indole-2-carboxylic acid-n-(1,4-benzodiazepin-3-yl) amides
PT92494A (pt) Processo para a preparacao de novos derivados do indol
ATE6635T1 (de) Biologisch aktive trizyklische amine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DK274082A (da) Fremgangsmaade til fremstilling af 2-acylaminomethyl-1,4-benzodiazepin-forbindelser og mellemprodukter til brug herved
ES528712A0 (es) Procedimiento para preparar nuevos compuestos heterociclicos
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.